Stephen R Durham

Stephen R Durham

Imperial College London

H-index: 158

Europe-United Kingdom

About Stephen R Durham

Stephen R Durham, With an exceptional h-index of 158 and a recent h-index of 75 (since 2020), a distinguished researcher at Imperial College London, specializes in the field of Allergy, Allergen immunotherapy, Asthma, Allergic rhinitis.

His recent articles reflect a diverse array of research interests and contributions to the field:

Allergen Immunotherapy in combination with biologicals for inhalant allergy: what do we really know?

Sublingual tablet immunotherapy improves quality of life in adults with allergic rhinoconjunctivitis

Allergen Immunotherapy: The Evidence Supporting the Efficacy and Safety of Subcutaneous Immunotherapy and Sublingual Forms of Immunotherapy for Allergic Rhinitis/Conjunctivitis …

Nasal allergen‐neutralizing antibodies correlate closely with tolerated intranasal allergen challenge dose following grass pollen subcutaneous immunotherapy in patients with …

Prevention is better than cure: impact of allergen immunotherapy on the progression of airway disease

Updated grading system for systemic allergic reactions: Joint Statement of the World Allergy Organization Anaphylaxis Committee and Allergen Immunotherapy Committee

Allergen-specific immunotherapy for allergic asthma: What’s new?

First-in-class biologic to treat human allergy to cats

Stephen R Durham Information

University

Position

___

Citations(all)

101246

Citations(since 2020)

24572

Cited By

85797

hIndex(all)

158

hIndex(since 2020)

75

i10Index(all)

463

i10Index(since 2020)

300

Email

University Profile Page

Imperial College London

Google Scholar

View Google Scholar Profile

Stephen R Durham Skills & Research Interests

Allergy

Allergen immunotherapy

Asthma

Allergic rhinitis

Top articles of Stephen R Durham

Title

Journal

Author(s)

Publication Date

Allergen Immunotherapy in combination with biologicals for inhalant allergy: what do we really know?

Allergo Journal

Stephen R Durham

2024/5

Sublingual tablet immunotherapy improves quality of life in adults with allergic rhinoconjunctivitis

The Journal of Allergy and Clinical Immunology: In Practice

Michael S Blaiss

Stephen R Durham

David Bernstein

Thomas Stranzl

Morten Lindholm

...

2024/2/1

Allergen Immunotherapy: The Evidence Supporting the Efficacy and Safety of Subcutaneous Immunotherapy and Sublingual Forms of Immunotherapy for Allergic Rhinitis/Conjunctivitis …

Peter Socrates Creticos

Fatma E Gunaydin

Hendrik Nolte

Cecilia Damask

Stephen R Durham

2024/4/27

Nasal allergen‐neutralizing antibodies correlate closely with tolerated intranasal allergen challenge dose following grass pollen subcutaneous immunotherapy in patients with …

Allergy

Ibon Eguiluz‐Gracia

Rebecca V Parkin

Janice A Layhadi

Elizabeth Palmer

Xun Meng

...

2024/3/14

Prevention is better than cure: impact of allergen immunotherapy on the progression of airway disease

The Journal of Allergy and Clinical Immunology: In Practice

Hasan Arshad

Gideon Lack

Stephen R Durham

Martin Penagos

Désireé Larenas-Linnemann

...

2024/1/1

Updated grading system for systemic allergic reactions: Joint Statement of the World Allergy Organization Anaphylaxis Committee and Allergen Immunotherapy Committee

Paul J Turner

Ignacio J Ansotegui

Dianne E Campbell

Victoria Cardona

Stuart Carr

...

2024/3/1

Allergen-specific immunotherapy for allergic asthma: What’s new?

Exploration of Asthma & Allergy

Chiara Asperti

Martin Penagos

Stephen R Durham

2024/2/29

First-in-class biologic to treat human allergy to cats

Journal of Allergy and Clinical Immunology

Guy Tropper

Virginie Stordeur

Réjean Desgagnés

Bertrand Morel

Anne-Catherine Fitchette

...

2024/2/1

A novel therapeutic approach for cat allergy using Fel d 1 expressing bioparticles

Journal of Allergy and Clinical Immunology

Janice Leyhadi

Lily Wu

Nichell Ann Samson

Paulina Filipaviciute

Roudin Sarama

...

2023/2/1

Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA‐MeDALL hypothesis

J Bousquet

E Melén

T Haahtela

GH Koppelman

A Togias

...

2023/2/17

Nomenclature of allergic diseases and hypersensitivity reactions: Adapted to modern needs: An EAACI position paper

Allergy

Marek Jutel

Ioana Agache

Magdalena Zemelka‐Wiacek

Mübeccel Akdis

Tomás Chivato

...

2023/11

Single-cell RNA-Seq identifies precise tolerogenic cellular and molecular pathways induced by depigmented-polymerized grass pollen allergen extract

Journal of Allergy and Clinical Immunology

Janice Layhadi

Raquel Moya Lobo

Tan Tiak Ju

Madison Burki

Hanisah Hj Awg Sharif Hj Awg

...

2023/2/1

Allergen immunotherapy: past, present and future

Stephen R Durham

Mohamed H Shamji

2023/5

Nasal and blood transcriptomic pathways underpinning the clinical response to grass pollen immunotherapy

Journal of Allergy and Clinical Immunology

Matthew C Altman

R Max Segnitz

David Larson

Naresh Doni Jayavelu

Malisa T Smith

...

2023/11/1

Allergen injection immunotherapy

Eva-Maria Varga

Stephen R Durham

2023/1/6

Obituary: Jörg Kleine-Tebbe

Allergy

Stephanie Dramburg

Susanne Lau

Paolo Matricardi

Margitta Worm

As Friends

...

2023/4

Standardization of clinical outcomes used in allergen immunotherapy in allergic asthma: An EAACI position paper

Allergy

Jasper Kappen

Zuzana Diamant

Ioana Agache

Matteo Bonini

Jean Bousquet

...

2023/11

Celebrating 75 years of BSACI

Pamela W Ewan

Stephen R Durham

Glenis K Scadding

Stephen T Holgate

2023/12

Is “maintenance” a misnomer? A narrative framework setting the right expectations of allergen immunotherapy

The Journal of Allergy and Clinical Immunology: In Practice

Kymble Spriggs

Oliver Pfaar

Ruby Pawankar

Stephen Durham

2023/7/1

Immunological mechanisms of tolerance: Central, peripheral and the role of T and B cells

Xun Meng

Janice A Layhadi

Sean T Keane

Natanya JK Cartwright

Stephen R Durham

...

2023/12/1

See List of Professors in Stephen R Durham University(Imperial College London)